These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36853386)

  • 1. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships.
    Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
    Eur J Clin Pharmacol; 2023 Apr; 79(4):553-567. PubMed ID: 36853386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.
    Greenland M; Knuiman MW; Hung J; Nedkoff L; Arnet I; Rankin JM; Kilkenny MF; Sanfilippo FM
    Sci Rep; 2020 Mar; 10(1):4315. PubMed ID: 32152400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients.
    Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):208-218. PubMed ID: 31958191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
    Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
    Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
    Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S
    ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
    Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
    J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.
    Lu L; Jackevicius CA; de Leon NK; Warner AL; Chang DS; Mody FV
    Clin Ther; 2017 Jun; 39(6):1200-1209. PubMed ID: 28545803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
    Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
    J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
    Teng TH; Hung J; Finn J
    Med J Aust; 2010 Mar; 192(6):306-10. PubMed ID: 20230346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
    Vaduganathan M; Greene SJ; Zhang S; Solomon N; Chiswell K; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Mcdermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Fonarow GC
    J Card Fail; 2022 Apr; 28(4):554-563. PubMed ID: 34785402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients.
    Scalvini S; Bernocchi P; Villa S; Paganoni AM; La Rovere MT; Frigerio M
    Int J Cardiol; 2021 May; 330():106-111. PubMed ID: 33582198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors.
    Pierce JB; Blumer V; Choi S; Hardy NC; Greiner MA; Carnicelli AP; Shen X; Lippmann SJ; Peterson PN; Allen LA; Fonarow GC; Mentz RJ; Greene SJ; O'Brien EC
    Am J Cardiol; 2023 Oct; 204():151-158. PubMed ID: 37544137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to heart failure management medications following cardiac resynchronization therapy.
    Shah BR; DerSarkissian M; Tsintzos SI; Xiao Y; May D; Lu X; Kinrich D; Davis E; Lefebvre P; Duh MS; Dasta JF
    Curr Med Res Opin; 2020 Feb; 36(2):199-207. PubMed ID: 31535559
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
    Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
    Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
    Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.